Stilo Share Price (STL)

Ouch

£5 million spent developing AuthorBridge.
£1 million in the bank.
First "large shipment" of AuthorBridge this June.
Cost saving "Organisational and management changes that are currently underway."
30% of equity being tendered for @ 1p.
Equity = £4 million +
IBM still according praise on AB3.
New clients include VISA, Mastercard and Intel.
STILO looks incredibly cheap on a Market cap of £1.4 million with the shares quoted @ just 1.25 pence.

Wow.. wtf.. Argh bad day for my portfolio.. this is it for me i'm out.. putting my money in PRD.L quick upside CEO owns 50% of company 5m MCAP 3 assets, news incoming extremely soon... huge upside potential.. CEO said DIV will be paid.. insanely low in point before news starts.. wont be long to get in. easily could be £1 by year end huge upside no downside at these levels.

DITA authoring at IBM: All of the power—none of the pain
Mike Iantosca, IBM and Patrick Baker, Stilo April 2019

"For most subject matter experts, authoring rich semantic content is considered too difficult. The prospect of learning DITA is something they have little or no tolerance for, they typically want to continue authoring in Word, or a Word-like authoring environment, and understandably don’t want to learn about XML.

This was the problem faced by the central ID Tools team at IBM—led by Mike Iantosca. With more than 5 million DITA topics and thousands of content contributors, they needed a low-cost, easy-to-use structured authoring tool that would win over the occasional contributors without compromising on structure – so they collaborated with Stilo on the development of AuthorBridge.

Join us for this session to learn from Mike about the implementation of AuthorBridge at IBM—he’ll touch on the integration with their CCMS and how users were able to virtually walk-up and use with minimal training, as well as the wider business benefits for intelligent content authoring.

Stilo’s Patrick Baker will follow-on from Mike to provide a live demonstration of AuthorBridge and talk about the unique architecture that makes all the above possible, as well as highlight significant new features for 2019."

Although the share price is at the bottom of its 10 year trading range and whilst the BOD issued a rather cautionary AGM statement ,it is safe to say that Migrate and AuthorBridge are making inroads into the market place.

The Rapid Prototyping Program combines validated content management technology from Astoria Software, process automation technology from TransPerfect, critical conversion technology from Stilo and information development services from leading consultant Mekon."

With "TransPerfect’s Rapid Prototyping Program now enabling device makers to build an evidence-based business case for management approval."(July 18th 2019)

"Industry-wide, the cost of implementing the EU’s new MDR and IVDR requirements is estimated at nearly $20 billion. A significant portion of that cost is due to new content requirements. Says TransPerfect MDS President Marc Miller, “Two critical areas affected by MDR and IVDR are labeling – including translations – and post-market surveillance. The new regulations will create a substantial, permanent increase in the volume and velocity of content in both of these areas. The only practical way to address this increase is through automation and AI.”

The Transperfect collaboration swiftly followed on from Componize Software and Stilo International announcing their partnership and product integration where "AuthorBridge offers an optimal authoring experience for SMEs, and integrates perfectly with Componize’s CCMS".

ALSO,Stilo has recently announced(without any fanfare)maiden contracts with both Intel and Visa !

It is exceedingly reassuring that Mike Iantosca, leader of IBM's central ID Tools team, continues in 2019 to oversee the implementation and integration of AuthorBridge thus enabling their CCMS users with the ability to virtually walk-up and use with minimal training, as well as providing the wider business benefits for intelligent content authoring.

It is also worth noting that, irrespective of the current waves of negativity,Chairman David Ashman stated in the Prelims, released in March,that we, "look forward to growing future sales, supported by healthy cash reserves and a strong balance sheet".

INTERESTING